|
Index of reports
> Cases with Dyspnoea ()
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Mylotarg (Gemtuzumab Ozogamicin) where reactions include dyspnoea. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Mylotarg side effects in 74 year old male
Reported by a physician from United States on 2011-12-27
Patient: 74 year old male, weighing 92.0 kg (202.4 pounds)
Reactions: Vomiting, Dyspnoea, Nausea, Tachycardia, Febrile Neutropenia, Atrial Fibrillation, Multi-Organ Failure, Sepsis, Tachypnoea
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Azacitidine
Dosage: 75mg/m2 on days 1-7, 160mg per day, total dose administered this course 1121mg
Indication: Acute Myeloid Leukaemia
Start date: 2011-11-15
End date: 2011-11-21
Mylotarg
Dosage: 3 mg/m2 over 2 hours on day 8, total dose administered this course 6.45mg
Indication: Acute Myeloid Leukaemia
Start date: 2011-11-22
End date: 2011-11-22
|
